Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
GZPHF
$2.35
-$0.015-0.64%
OTC PK
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -13.89% | 41.40% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -13.34% | 39.50% | |||
| Cost of Revenue | -8.09% | 26.97% | |||
| Gross Profit | -33.68% | 125.86% | |||
| SG&A Expenses | -8.36% | 13.88% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 673.81% | -86.97% | |||
| Total Operating Expenses | -7.35% | 23.66% | |||
| Operating Income | -69.67% | 780.86% | |||
| Income Before Tax | -61.25% | 653.73% | |||
| Income Tax Expenses | -62.04% | 436.61% | |||
| Earnings from Continuing Operations | -61.09% | 736.27% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 34.18% | -2.78% | |||
| Net Income | -61.62% | 656.83% | |||
| EBIT | -69.67% | 780.86% | |||
| EBITDA | -64.88% | 1,482.51% | |||
| EPS Basic | -61.62% | 655.96% | |||
| Normalized Basic EPS | -71.40% | 791.02% | |||
| EPS Diluted | -61.62% | 655.96% | |||
| Normalized Diluted EPS | -71.40% | 791.02% | |||
| Average Basic Shares Outstanding | -0.09% | 0.01% | |||
| Average Diluted Shares Outstanding | -0.09% | 0.01% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | 19.46% | 1.02% | |||